218 related articles for article (PubMed ID: 11726136)
1. Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use.
Spisek R; Bretaudeau L; Barbieux I; Meflah K; Gregoire M
Cancer Immunol Immunother; 2001 Oct; 50(8):417-27. PubMed ID: 11726136
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination.
Pedersen AE; Thorn M; Gad M; Walter MR; Johnsen HE; Gaarsdal E; Nikolajsen K; Buus S; Claesson MH; Svane IM
Scand J Immunol; 2005 Feb; 61(2):147-56. PubMed ID: 15683451
[TBL] [Abstract][Full Text] [Related]
3. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression.
Bernhard H; Huseby ES; Hand SL; Lohmann M; Batten WY; Disis ML; Gralow JR; Meyer zum Büschenfelde KH; Ohlén C; Cheever MA
Immunobiology; 2000 Apr; 201(5):568-82. PubMed ID: 10834314
[TBL] [Abstract][Full Text] [Related]
5. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.
Dauer M; Obermaier B; Herten J; Haerle C; Pohl K; Rothenfusser S; Schnurr M; Endres S; Eigler A
J Immunol; 2003 Apr; 170(8):4069-76. PubMed ID: 12682236
[TBL] [Abstract][Full Text] [Related]
6. A two-step culture method starting with early growth factors permits enhanced production of functional dendritic cells from murine splenocytes.
Berthier R; Martinon-Ego C; Laharie AM; Marche PN
J Immunol Methods; 2000 May; 239(1-2):95-107. PubMed ID: 10821951
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.
Kaliński P; Schuitemaker JH; Hilkens CM; Kapsenberg ML
J Immunol; 1998 Sep; 161(6):2804-9. PubMed ID: 9743339
[TBL] [Abstract][Full Text] [Related]
8. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
9. The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro.
Chen B; Shi Y; Smith JD; Choi D; Geiger JD; Mulé JJ
Blood; 1998 Jun; 91(12):4652-61. PubMed ID: 9616162
[TBL] [Abstract][Full Text] [Related]
10. Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.
Morse MA; Zhou LJ; Tedder TF; Lyerly HK; Smith C
Ann Surg; 1997 Jul; 226(1):6-16. PubMed ID: 9242332
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells.
Matasić R; Dietz AB; Vuk-Pavlović S
J Leukoc Biol; 1999 Dec; 66(6):909-14. PubMed ID: 10614771
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two different protocols for the induction of maturation of human dendritic cells in vitro.
Colić M; Mojsilović S; Pavlović B; Vucićević D; Majstorović I; Bufan B; Stojić-Vukanić Z; Vasilijić S; Vucević D; Gasić S; Balint B
Vojnosanit Pregl; 2004; 61(5):471-8. PubMed ID: 15551798
[TBL] [Abstract][Full Text] [Related]
13. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
[TBL] [Abstract][Full Text] [Related]
14. Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli RM
Exp Hematol; 2000 Aug; 28(8):931-40. PubMed ID: 10989194
[TBL] [Abstract][Full Text] [Related]
15. The gp130-stimulating designer cytokine hyper-IL-6 promotes the expansion of human hematopoietic progenitor cells capable to differentiate into functional dendritic cells.
Bernhard H; Lohmann M; Batten WY; Metzger J; Löhr HF; Peschel C; zum Büschenfelde KM; Rose-John S
Exp Hematol; 2000 Apr; 28(4):365-72. PubMed ID: 10781894
[TBL] [Abstract][Full Text] [Related]
16. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.
Ebner S; Hofer S; Nguyen VA; Fürhapter C; Herold M; Fritsch P; Heufler C; Romani N
J Immunol; 2002 Jun; 168(12):6199-207. PubMed ID: 12055233
[TBL] [Abstract][Full Text] [Related]
17. Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate.
Chiang CL; Maier DA; Kandalaft LE; Brennan AL; Lanitis E; Ye Q; Levine BL; Czerniecki BJ; Powell DJ; Coukos G
J Transl Med; 2011 Nov; 9():198. PubMed ID: 22082029
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines.
Takahashi A; Kono K; Ichihara F; Sugai H; Fujii H; Matsumoto Y
Cancer Immunol Immunother; 2004 Jun; 53(6):543-50. PubMed ID: 14666382
[TBL] [Abstract][Full Text] [Related]
19. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells.
Czerniecki BJ; Carter C; Rivoltini L; Koski GK; Kim HI; Weng DE; Roros JG; Hijazi YM; Xu S; Rosenberg SA; Cohen PA
J Immunol; 1997 Oct; 159(8):3823-37. PubMed ID: 9378970
[TBL] [Abstract][Full Text] [Related]
20. Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.
Truxova I; Pokorna K; Kloudova K; Partlova S; Spisek R; Fucikova J
Immunol Lett; 2014 Jul; 160(1):39-49. PubMed ID: 24726860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
